Acute systolic (congestive) heart failure
ICD-10 I50.21 is a billable code used to indicate a diagnosis of acute systolic (congestive) heart failure.
Acute systolic (congestive) heart failure (CHF) is characterized by the heart's inability to pump blood effectively, leading to inadequate perfusion of tissues and fluid accumulation in the lungs and other tissues. Clinically, patients may present with symptoms such as dyspnea, fatigue, and edema. The left ventricle is primarily involved, often due to conditions such as ischemic heart disease, hypertension, or valvular heart disease. Disease progression can vary, with acute episodes potentially leading to chronic heart failure if not managed effectively. Diagnostic considerations include clinical evaluation, echocardiography to assess ejection fraction, and biomarkers such as B-type natriuretic peptide (BNP) levels. Management typically involves diuretics, ACE inhibitors, beta-blockers, and lifestyle modifications. Early recognition and treatment are crucial to prevent further cardiac deterioration and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I50.21 specifically covers acute systolic heart failure, which may arise from acute myocardial infarction, severe hypertension, or acute valvular dysfunction. It is characterized by a reduced ejection fraction and clinical signs of congestion.
I50.21 should be used when the patient presents with acute symptoms of heart failure with reduced ejection fraction. It is essential to differentiate it from chronic heart failure codes or acute diastolic heart failure (I50.22) based on clinical presentation and diagnostic findings.
Documentation should include clinical findings such as symptoms of heart failure, results from echocardiograms showing reduced ejection fraction, and any relevant laboratory tests like BNP levels. Clear notes on the acute nature of the condition and treatment provided are also necessary.
